Help Research New Treatments
Our office participates in Phase II, III and IV pharmaceutical (drug) trials.
These studies involve medications both FDA approved and currently on the market in the United States. Patients usually receive free study medications as well as compensation for study visits.
I believe that this is an excellent opportunity for you to become involved in the development of new medications and in the improvement of currently marketed drugs. Patients who participate in studies currently ongoing in my office, as well as those who have participated in the past, have been very supportive and appreciative of their involvement in clinical research. They learn about their eye conditions, current and future treatments, and they also get to be a part of the drug development process that helps bring new therapies to millions of eye patients worldwide.
If you would like to hear more about the studies we offer, or you would like to enroll, please telephone our office at (310) 657-2777 , e-mail Scott at email@example.com, or fill out the simple form at the bottom of the page.
Medical Legal Consultation
As a California state certified QME (Qualified Medical Evaluator), Dr. Macy often is requested to do IME (Independent Medical Evaluations) or AME (Agreed Medical Evaluations) in Workman's Compensation cases. Appointments are scheduled promptly. Thorough, objective and accurate evaluations are done, followed by prompt, clear and useful reports.
After years of expert experience, Dr. Macy makes time available to review Medical Malpractice records and Personal Injury matters. A CV (Curriculum Vitae) is available upon request, as well as a listing of fees.
Dr. Jonathan I. Macy has presented more than 300 talks around the world, ranging from radio and television to international symposiums. He makes time to speak to patient groups, sometimes related to his positions as Chairman of the Board of the Foundation for the Junior Blind and Vice President of the Myasthenia Gravis Foundation. Through extensive experience with clinical research, Dr. Macy is able to talk about both the current state and the future of eye disease and therapy. A sample of recent presentations include:
The Effect of ABO Blood Incompatibility on Corneal Transplant Failure in Conditions with Low Risk of Graft Rejection
American Academy of Ophthalmology, November 2008.
Moderator, 40th Annual Doheny Days and Alumni/Residents Conference, Doheny Eye Institute/University of Southern California, June 2009.
What’s Your Specialty?
National Youth Leadership Forum, July 2009.
2nd Year Medical Student Workshop
UCLA School of Medicine, September 2009.
Jules Stein Eye Institute, October 2009.
The Treatment of Ocular Surface Inflammatory Conditions
Bausch & Lomb Dinner Symposium, March 2010.